Uzbekistan Digital Health Platform
0.3.0 -
Uzbekistan Digital Health Platform
0.3.0 -
Uzbekistan Digital Health Platform, published by Uzinfocom LLC. This guide is not an authorized publication; it is the continuous build for version 0.3.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/vadi2/DHP-temp/ and changes regularly. See the Directory of published versions
| Official URL: https://dhp.uz/fhir/core/ValueSet/service-names-vs | Version: 0.3.0 | |||
| Computable Name: ServiceNamesVS | ||||
Defines the actual cancer-related services in Uzbek and Russian
References
Language: uz
This value set includes codes based on the following rules:
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs version 📦0.3.0This value set excludes codes based on the following rules:
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs version 📦0.3.0| Code | Display |
| cancr0003.00000 | IHC nonspesifik_antikorlari |
| cancr0005.00000 | Molekulyar genetik tadqiqotlar markerlari |
| cancr0012.00000 | IHCga xos gormonlar immunohistokimyosi |
| cancr0013.00000 | Tadqiqot nomi |
| cancr0022.00000 | Onkologik operatsiyalar |
| cancr0043.00000 | Boshqa ta'sir turlari |
Expansion performed internally based on codesystem Cancer Types v0.3.0 (CodeSystem)
This value set contains 579 concepts
| System | Code | Display (uz) | Definition | JSON | XML |
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00001 | pS2 (TFF1, Trefoil Factor 1) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00002 | Bcl-2(B-cell lymphoma 2) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00003 | P53(Tumor Protein 53) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00004 | CD3(Protein complex) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00005 | CD4 (Glycoprotein) in patients with HIV/AIDS. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00006 | CD5(Protein) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00007 | CD8 (Glycoprotein) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00008 | CD10 (Membrane protein) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00009 | CD15 (Surface antigen) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00010 | CD20 (Protein expressed on the surface of B-lymphocytes) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00011 | CD23 (Surface antigen expressed on some B lymphocytes) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00012 | CD30 (Membrane protein expressed on activated lymphocytes) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00013 | CD79 α (A protein that is a component of the B-cell antigen receptor) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00014 | CD99 (A membrane protein used as a marker for the diagnosis of Ewing's sarcoma and other primitive neuroectodermal tumors) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00015 | CD117 (A protein also known as c-Kit) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00016 | CD138 (A membrane protein also known as syndecan-1) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00017 | CD34 (A glycoprotein expressed on stem and progenitor cells. Used to identify hematopoietic stem cells) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00018 | CD45 (OLA) (A protein expressed on all types of white blood cells. Used to identify and study white blood cells | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00019 | Pan-B (A pan-B cell marker used to identify all B lymphocytes) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00020 | Pan-T A pan-T cell marker used to identify all T lymphocytes | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00021 | BLA-36 A specific marker for B cells and some lymphomas. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00022 | TDT (Terminal deoxynucleotidyl transferase) A protein expressed early in the development of lymphoid cells | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00023 | λ chains (Immunoglobulin light chains used to determine clonality in B-cell malignancies) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00024 | κ chains (Immunoglobulin light chains used to determine clonality in B-cell malignancies) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00025 | Cyclin D1 Protein involved in cell cycle regulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00026 | Bcl-2 Proto-oncogene that inhibits apoptosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00027 | Bcl-6 Transcription factor involved in B-cell regulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00028 | MPO (Myeloperoxidase): An enzyme expressed in granulocytes. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00029 | CD68 A protein expressed on macrophages | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00030 | CKR-PAN (Cytokeratin-Pan): A marker used to identify all types of epithelial cells. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00031 | EMA (Epithelial Membrane Antigen): A marker used to identify epithelial tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00032 | BER-EP-4 An antibody used to identify epithelial cells, especially in the diagnosis of carcinomas. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00033 | TTF-1 (Thyroid Transcription Factor-1): A transcription factor expressed in thyroid and lung cells | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00034 | GFAP (Glial Fibrillary Acidic Protein): A protein expressed in glial cells. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00035 | EGFR (HER-1) Epidermal growth factor receptor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00036 | CKR 7 (Cytokeratin 7): A marker used to diagnose adenocarcinomas and other epithelial tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00037 | Cytokeratin 8: A marker used to diagnose various carcinomas. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00038 | Cytokeratin 19: A marker used to diagnose metastatic carcinomas. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00039 | Cytokeratin 20: A marker used to diagnose colorectal and other adenocarcinomas. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00040 | Cytokeratin-squamous: A marker for diagnosing squamous cell carcinomas. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00041 | CEA (Carcinoembryonic Antigen): A protein used as a tumor marker for diagnosing and monitoring cancer. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00042 | PSA (Prostate-Specific Antigen): A protein used as a marker for diagnosing and monitoring prostate cancer. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00043 | AR (Androgen Receptor): An androgen receptor used to diagnose and research prostate cancer. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00044 | Vimentin An intermediate filament protein used to identify mesenchymal cells and diagnose sarcomas. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00045 | Desmin An intermediate filament protein expressed in muscle cells. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00046 | Pan-actin: A protein used to identify actin filaments in cells. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00047 | α-Smooth Muscle Actin: A smooth muscle cell marker used to diagnose smooth muscle tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00048 | E-cadherin: An adhesion protein used to diagnose adenocarcinomas. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00049 | P63 A transcription factor used to diagnose squamous cell carcinomas and other tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00050 | Collagen IV A protein used to diagnose basement membrane diseases. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00051 | NF (Neurofilament): A protein expressed in neurons. Used to diagnose neuronal tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00052 | MBP (Myoglobin): A protein used to diagnose muscle damage. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00053 | NSE (Neuron-Specific Enolase): A protein used to diagnose neuroendocrine tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00054 | S100 A protein used to diagnose melanoma and other tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00055 | HMB-45 An antibody used to diagnose melanoma. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00056 | α-1-Antitrypsin: A protein used to diagnose liver and lung disease. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00057 | HBME-1 An antibody used to diagnose mesothelioma. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00058 | Calcitonin: A hormone used to diagnose medullary thyroid cancer. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00059 | Thyroglobulin: A protein used to monitor thyroid cancer. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00060 | Synaptophysin: A protein used to diagnose neuroendocrine tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00061 | Chromogranin (Chromogranin) A glycoprotein expressed in neuroendocrine cells. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00062 | AFP (Alpha-Fetoprotein) A protein that is normally produced by the liver and yolk sac of the fetus | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00063 | PLAP (Placental Alkaline Phosphatase) An enzyme expressed in the placenta | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00064 | VEGF (Vascular Endothelial Growth Factor) A protein that stimulates the growth of new blood vessels | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00065 | VEGFR (Vascular Endothelial Growth Factor Receptor) A receptor for VEGF involved in angiogenesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00066 | ALK (Anaplastic Lymphoma Kinase) A tyrosine kinase involved in cell growth | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00067 | p16 (Cyclin-Dependent Kinase Inhibitor 2A) A protein that inhibits the cell division cycle | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00068 | Amacr Amacr (Alpha-Methylacyl-CoA Racemase) An enzyme involved in the metabolism of fatty acids | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00069 | Androgen R (Androgen Receptor) Androgen receptor involved in the regulation of male sexual characteristics | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00070 | Annexin A1 Protein involved in inflammatory processes and the regulation of apoptosis. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0003.00071 | Arginase-1 Enzyme involved in the metabolism of arginine | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00001 | ABCB11 ATP-Binding Cassette Sub-Family B Member 11) Protein, bile acid transporter in the liver | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00002 | ABRAXAS1 (FAM175A) Protein involved in DNA repair. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00003 | ACD (Adrenocortical Dysplasia Homolog) Protein involved in telomere maintenance | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00004 | AIP (Aryl Hydrocarbon Receptor Interacting Protein) Protein that regulates the functions of the aryl hydrocarbon receptor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00005 | AKT1 (AKT Serine/Threonine Kinase 1) Kinase involved in signaling pathways regulating cell growth and survival | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00006 | ALK (Anaplastic Lymphoma Kinase) Tyrosine kinase involved in cell growth | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00007 | ANKRD26 (Ankyrin Repeat Domain 26) A protein of unknown precise function, but mutations are associated with inherited forms of thrombocytopenia and myeloid neoplasia. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00008 | APC (Adenomatous Polyposis Coli) A tumor suppressor protein involved in cell cycle regulation. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00009 | AR (Androgen Receptor) Androgen receptor involved in regulating male sexual characteristics | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00010 | ASCC1 (Activating Signal Cointegrator 1 Complex Subunit 1) Protein involved in regulating transcription and DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00011 | ASXL1 (Additional Sex Combs Like 1) Protein involved in regulating transcription | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00012 | ATM (Ataxia Telangiectasia Mutated) Protein that plays a key role in DNA repair and cell cycle regulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00013 | ATP8B1 (ATPase Phospholipid Transporting 8B1) Protein involved in phospholipid transport | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00014 | ATR (ATR Serine/Threonine Kinase) Kinase that plays a key role in DNA damage response and repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00015 | AXIN2 (Axis Inhibition Protein 2) Protein involved in regulating the Wnt signaling pathway. Mutations are associated with an increased risk of colorectal cancer. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00016 | BAP1 (BRCA1 Associated Protein 1) Deubiquitinase involved in cell cycle regulation and DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00017 | BARD1 (BRCA1 Associated RING Domain 1) Protein interacting with BRCA1 and involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00018 | BLM (Bloom Syndrome, RecQ Helicase-Like) Helicase involved in DNA repair. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00019 | BMPR1A (Bone Morphogenetic Protein Receptor Type 1A) Bone morphogenetic protein receptor involved in the regulation of growth and development | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00020 | BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase) Kinase involved in the MAPK/ERK signaling pathway | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00021 | BRCA1(Breast Cancer 1) Tumor suppressor protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00022 | BRCA2 (Breast Cancer 2) Tumor suppressor protein involved in DNA repair. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00023 | BRIP1 (BRCA1 Interacting Protein C-Terminal Helicase 1) Helicase interacting with BRCA1 and involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00024 | BTNL2 (Butyrophilin-Like 2) Protein involved in the regulation of the immune response | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00025 | BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) Kinase playing a role in the mitotic checkpoint | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00026 | CBL (Casitas B-Lineage Lymphoma) Ubiquitin ligase involved in the regulation of protein degradation. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00027 | CDC73 (Cell Division Cycle 73) Protein involved in cell cycle regulation and tumor suppression. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00028 | CDH1 (Cadherin 1) Cell adhesion protein that plays a key role in maintaining cell adhesion | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00029 | CDK4 (Cyclin Dependent Kinase 4) Kinase that regulates the cell cycle. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00030 | CDKN1B (Cyclin Dependent Kinase Inhibitor 1B) Inhibitor of kinases that regulate the cell cycle | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00031 | CDKN1C (Cyclin Dependent Kinase Inhibitor 1C) Inhibitor of kinases that regulate the cell cycle | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00032 | CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) Inhibitor of kinases that regulate the cell cycle | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00033 | CEBPA (CCAAT Enhancer Binding Protein Alpha) Transcription factor that regulates cell differentiation and proliferation. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00034 | CEP57 (Centrosomal Protein 57) A protein involved in the organization of microtubules | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00035 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) An ion channel that regulates the transport of chloride ions | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00036 | CHEK2 (Checkpoint Kinase 2) A kinase involved in the regulation of the cell cycle and the response to DNA damage | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00037 | CTC1 (CST Telomere Replication Complex Component 1) A protein involved in the maintenance of telomeres | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00038 | CTHRC1 (Collagen Triple Helix Repeat Containing 1) A protein involved in the remodeling of the extracellular matrix | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00039 | CTNNA1 (Catenin Alpha 1) A protein involved in cell adhesion and signaling pathways | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00040 | CTRC (Chymotrypsin C) An enzyme involved in digestion | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00041 | CYLD (Cylindromatosis) A tumor suppressor protein involved in the regulation of the cell cycle and apoptosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00042 | CYP21A2 (Cytochrome P450 Family 21 Subfamily A Member 2) An enzyme involved in the synthesis of steroid hormones | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00043 | DCLRE1C (DNA Cross-Link Repair 1C) A protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00044 | DDB2 (Damage Specific DNA Binding Protein 2) A protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00045 | DDX41 (DEAD-Box Helicase 41) A helicase involved in RNA metabolism | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00046 | DICER1 (Dicer 1, Ribonuclease III) An enzyme involved in the biogenesis of microRNA | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00047 | DIS3L2 (DIS3 Like 3'-5' Exoribonuclease 2) An exoribonuclease involved in RNA degradation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00048 | DKC1 (Dyskerin Pseudouridine Synthase 1) A protein involved in the modification of ribosomal RNA and telomere maintenance | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00049 | DOCK8 (Dedicator of Cytokinesis 8) A protein involved in the regulation of actin | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00050 | EGFR (Epidermal Growth Factor Receptor) An epidermal growth factor receptor growth factor involved in the regulation of cell growth and differentiation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00051 | EGLN1 (Egl-9 Family Hypoxia Inducible Factor 1) An enzyme involved in the regulation of the response to hypoxia | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00052 | ELAC2 (ElaC Ribonuclease Z 2) An enzyme involved in the processing of pre-tRNA | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00053 | ELANE (Elastase, Neutrophil Expressed) An enzyme involved in the degradation of extracellular matrix proteins. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00054 | EPCAM (Epithelial Cell Adhesion Molecule) A protein involved in cell adhesion and signaling pathways | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00055 | ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2, also known as HER2) A tyrosine kinase receptor involved in the regulation of cell growth. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00056 | ERCC1 (ERCC Excision Repair 1, Endonuclease Non-Catalytic Subunit) Protein involved in nucleotide excision repair of DNA | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00057 | ERCC2 (ERCC Excision Repair 2, TFIIH Core Complex Helicase Subunit, also known as XPD) Helicase involved in nucleotide excision repair of DNA | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00058 | ERCC3 (ERCC Excision Repair 3, also known as XPB) Helicase involved in nucleotide excision repair of DNA. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00059 | ERCC4 (ERCC Excision Repair 4, also known as XPF) Protein involved in nucleotide excision repair of DNA. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00060 | ERCC5 (ERCC Excision Repair 5, also known as XPG) Protein involved in nucleotide excision repair of DNA. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00061 | ETV6 (ETS Variant Transcription Factor 6) Transcription factor involved in the regulation of hematopoiesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00062 | EXT1 (Exostosin Glycosyltransferase 1) Glycosyltransferase involved in the synthesis of heparan sulfate. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00063 | EXT2 (Exostosin Glycosyltransferase 2) Glycosyltransferase involved in the synthesis of heparan sulfate | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00064 | EZH2 (Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit) Protein involved in the regulation of transcription through chromatin modification | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00065 | FANCA (Fanconi Anemia Complementation Group A) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00066 | FANCB (Fanconi Anemia Complementation Group B): Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00067 | FANCC (Fanconi Anemia Complementation Group C) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00068 | FANCD2 (Fanconi Anemia Complementation Group D2) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00069 | FANCE (Fanconi Anemia Complementation Group E) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00070 | FANCF (Fanconi Anemia Complementation Group F) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00071 | FANCG (Fanconi Anemia Complementation Group G) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00072 | FANCI (Fanconi Anemia Complementation Group I) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00073 | FANCL (Fanconi Anemia Complementation Group L) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00074 | FANCM (Fanconi Anemia Complementation Group M) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00075 | FAS (Fas Cell Surface Death Receptor) Receptor regulating apoptosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00076 | FASLG (Fas Ligand) Fas receptor ligand involved in apoptosis induction | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00077 | FH (Fumarate Hydratase) Enzyme involved in the citric acid cycle. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00078 | FLCN (Folliculin) Tumor suppressor protein | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00079 | GALNT12 (Polypeptide N-Acetylgalactosaminyltransferase 12) Glycosyltransferase involved in O-glycosylation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00080 | GATA2 (GATA Binding Protein 2) Transcription factor involved in the regulation of hematopoiesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00081 | GEN1 (GEN1 Holliday Junction 5' Flap Endonuclease) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00082 | GNAS (GNAS Complex Locus) Protein involved in G-protein signaling pathways. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00083 | GPC3 (Glypican 3) Proteoglycan involved in the regulation of cell growth | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00084 | GREM1 (Gremlin 1, DAN Family BMP Antagonist) Protein involved in the regulation of bone morphogenesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00085 | HNF1A (Hepatocyte Nuclear Factor 1 Alpha) Transcription factor involved in the regulation of glucose metabolism | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00086 | HNF1B (Hepatocyte Nuclear Factor 1 Beta) Transcription factor involved in the regulation of glucose metabolism and organ development | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00087 | HOXB13 (Homeobox B13) Transcription factor involved in the development of the prostate gland | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00088 | HER2 (Human Epidermal Growth Factor Receptor 2, also known as ERBB2) Tyrosine kinase receptor involved in the regulation of cell growth. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00089 | HRAS (HRas Proto-Oncogene, GTPase) A protein involved in signaling pathways of cell growth and differentiation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00090 | IFNGR1 (Interferon Gamma Receptor 1) An interferon gamma receptor involved in immune regulation and antiviral protection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00091 | IKZF1 (IKAROS Family Zinc Finger 1) A transcription factor that regulates the development of lymphocytes. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00092 | JAK2 (Janus Kinase 2) A tyrosine kinase involved in signaling from cytokines to the cell nucleus | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00093 | JAK3 (Janus Kinase 3) A tyrosine kinase involved in signaling from cytokines to the cell nucleus, especially in immune cells | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00094 | KDR (Kinase Insert Domain Receptor, also known as VEGFR2) A tyrosine kinase receptor for vascular endothelial growth factor (VEGF), involved in angiogenesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00095 | KIF1B (Kinesin Family Member 1B) A protein involved in the transport of organelles along microtubules. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00096 | KIT (KIT Proto-Oncogene, Receptor Tyrosine Kinase) Tyrosine kinase receptor involved in the regulation of cell growth and differentiation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00097 | KRAS (KRAS Proto-Oncogene, GTPase) Protein involved in cell growth signaling pathways | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00098 | LIG4 (DNA Ligase IV) Ligase involved in the repair of double-strand DNA breaks | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00099 | LZTR1 (Leucine Zipper Like Transcription Regulator 1) Protein involved in the regulation of cell growth and apoptosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00100 | MAX (MYC Associated Factor X) Transcription factor involved in the regulation of cell growth and apoptosis. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00101 | MC1R (Melanocortin 1 Receptor) Receptor involved in the regulation of skin pigmentation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00102 | MEN1 (Menin 1) Tumor suppressor protein involved in the regulation of cell growth. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00103 | MET (MET Proto-Oncogene, Receptor Tyrosine Kinase) A tyrosine kinase receptor involved in the regulation of cell growth, survival, and migration | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00104 | MITF (Microphthalmia Associated Transcription Factor) A transcription factor involved in the development of melanocytes | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00105 | MLH1 (MutL Homolog 1) A protein involved in the repair of DNA mismatches | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00106 | MLH3 (MutL Homolog 3) A protein involved in the repair of DNA mismatches | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00107 | MRE11 (MRE11 Homolog, Double Strand Break Repair Nuclease) A protein involved in the repair of double-strand DNA breaks and the maintenance of genomic stability | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00108 | MSH2 (MutS Homolog 2) A protein involved in the repair of DNA mismatches. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00109 | MSH3 (MutS Homolog 3) A protein involved in DNA mismatch repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00110 | MSH6 (MutS Homolog 6) A protein involved in DNA mismatch repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00111 | MSR1 (Macrophage Scavenger Receptor 1) A protein involved in the immune response and clearance of oxidized lipids. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00112 | MUTYH (MutY DNA Glycosylase) A protein involved in base excision repair of DNA. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00113 | NBN (Nibrin) Protein involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00114 | NF1 (Neurofibromin 1) Tumor suppressor protein that regulates Ras signaling | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00115 | NF2 (Neurofibromin 2, Merlin) Tumor suppressor protein that regulates cell shape and movement | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00116 | NHEJ1 (Non-Homologous End-Joining Factor 1) Protein involved in non-homologous recombination during repair of double-strand DNA breaks | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00117 | NHP2 (NHP2 Ribonucleoprotein) Protein involved in ribosome biogenesis and telomeres | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00118 | NOP10 (NOP10 Ribonucleoprotein) Protein involved in ribosome biogenesis and telomeres | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00119 | NRAS (NRAS Proto-Oncogene, GTPase) Protein involved in cell growth signaling pathways | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00120 | NSD1 (Nuclear Receptor Binding SET Domain Protein 1) Histone methyltransferase involved in transcription regulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00121 | NTHL1 (Nth Like DNA Glycosylase 1) Protein involved in DNA base excision repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00122 | PALB2 (Partner And Localizer Of BRCA2) Protein interacting with BRCA2 and involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00123 | PALLD (Palladin) Cytoskeletal protein involved in the regulation of cell shape and motility. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00124 | PARN (Poly(A)-Specific Ribonuclease) A protein involved in mRNA processing | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00125 | PAX5 (Paired Box 5) A transcription factor involved in B-cell development | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00126 | PDGFRA (Platelet-Derived Growth Factor Receptor Alpha) A tyrosine kinase receptor involved in the regulation of cell growth and development | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00127 | PDGFRB (Platelet-Derived Growth Factor Receptor Beta) A tyrosine kinase receptor involved in the regulation of cell growth and development | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00128 | PHOX2B (Paired Like Homeobox 2b) A transcription factor important for the development of the nervous system. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00129 | PIK3CA (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha) The catalytic subunit of PI3K involved in cell growth signaling | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00130 | PIK3CD (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta) The catalytic subunit of PI3K involved in regulating the immune response. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00131 | PIK3R1 (Phosphoinositide-3-Kinase Regulatory Subunit 1) The regulatory subunit of PI3K involved in cell growth signaling | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00132 | PMS1 (PMS1 Homolog 1, Mismatch Repair System Component) A protein involved in DNA mismatch repair. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00133 | PMS2 (PMS1 Homolog 2, Mismatch Repair System Component) A protein involved in DNA mismatch repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00134 | POLD1 (DNA Polymerase Delta 1, Catalytic Subunit) The catalytic subunit of DNA polymerase delta involved in DNA repair and replication | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00135 | POLE (DNA Polymerase Epsilon, Catalytic Subunit) The catalytic subunit of DNA polymerase epsilon involved in DNA repair and replication | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00136 | POLH (DNA Polymerase Eta) DNA polymerase involved in translational synthesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00137 | POT1 (Protection Of Telomeres 1) A protein that protects telomeres from degradation and is involved in maintaining their length | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00138 | PRF1 (Perforin 1) A protein involved in cellular immunity, causing lysis of target cells. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00139 | PRKAR1A (Protein Kinase CAMP-Dependent Type I Regulatory Subunit Alpha) Regulatory subunit of protein kinase A, involved in various cellular processes | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00140 | PRSS1 (Protease, Serine 1) Trypsinogen, a pancreatic enzyme | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00141 | PTCH1 (Patched 1) Tumor suppressor protein involved in Hedgehog signaling | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00142 | PTCH2 (Patched 2) Protein similar to PTCH1, involved in Hedgehog signaling | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00143 | PTEN (Phosphatase And Tensin Homolog) Phosphatase that plays a role in regulating cell growth and survival. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00144 | PTPN11 (Protein Tyrosine Phosphatase Non-Receptor Type 11) Phosphatase involved in cell growth and differentiation signaling pathways | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00145 | RAD50 (RAD50 Double Strand Break Repair Protein) A protein involved in the repair of double-strand DNA breaks and maintaining genomic stability. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00146 | RAD51 (RAD51 Recombinase) A protein involved in homologous recombination and DNA repair. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00147 | RAD51C (RAD51 Paralog C) A protein involved in homologous recombination and DNA repair. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00148 | RAD51D (RAD51 Paralog D) A protein involved in homologous recombination and DNA repair. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00149 | RAF1 (Raf-1 Proto-Oncogene, Serine/Threonine Kinase) A kinase involved in the regulation of cell growth and differentiation. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00150 | RASAL1 (RAS Protein Activator Like 1) A protein that negatively regulates Ras signaling pathways | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00151 | RB1 (RB Transcriptional Corepressor 1) A tumor suppressor protein that regulates the cell cycle. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00152 | RECQL (RecQ Like Helicase) A helicase involved in DNA repair and maintaining genomic stability | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00153 | RECQL4 (RecQ Like Helicase 4) A helicase involved in DNA repair | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00154 | REST (RE1 Silencing Transcription Factor) A transcription factor that regulates the expression of genes important for the nervous system | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00155 | RET (Ret Proto-Oncogene) A tyrosine kinase receptor involved in the development of the nervous system and kidneys. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00156 | RHBDF2 (Rhomboid 5 Homolog 2) A protein involved in the regulation of the inflammatory response and wound healing. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00157 | RINT1 (RAD50 Interactor 1) A protein involved in DNA repair and maintenance of genomic stability. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00158 | RNASEL (Ribonuclease L) An endonuclease involved in the antiviral response | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00159 | RNF43 (Ring Finger Protein 43) An E3-ubiquitin ligase protein involved in the regulation of the Wnt signaling pathway. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00160 | RPS20 (Ribosomal Protein S20) A protein involved in ribosome biogenesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00161 | RRAS (Related RAS Viral (R-Ras) Oncogene Homolog) A protein involved in the regulation of cell growth and differentiation. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00162 | RTEL1 (Regulator Of Telomere Elongation Helicase 1) A helicase involved in the maintenance of telomere length and DNA repair. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00163 | RUNX1 (Runt-Related Transcription Factor 1) A transcription factor that plays an important role in the development of the hematopoietic system | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00164 | SAMD9L (Sterile Alpha Motif Domain Containing 9-Like) A protein involved in the regulation of cell growth and proliferation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00165 | SBDS (Shwachman-Bodian-Diamond Syndrome)A protein involved in ribosome biogenesis and cell growth | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00166 | SCG5 (Secretogranin V)A protein involved in the processing and sorting of neuropeptides and hormones. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00167 | SDHA (Succinate Dehydrogenase Complex Flavoprotein Subunit A) Subunit of succinate dehydrogenase, a key enzyme of the Krebs cycle and respiratory chain | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00168 | SDHAF2 (Succinate Dehydrogenase Complex Assembly Factor 2) Protein involved in the assembly of succinate dehydrogenase | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00169 | SDHB (Succinate Dehydrogenase Complex Iron Sulfur Subunit B) Subunit of succinate dehydrogenase | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00170 | SDHC (Succinate Dehydrogenase Complex Subunit C) Subunit of succinate dehydrogenase | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00171 | SDHD (Succinate Dehydrogenase Complex Subunit D) Subunit of succinate dehydrogenase | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00172 | SEC23B (Sec23 Homolog B) Protein involved in vesicular transport | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00173 | SH2D1A (SH2 Domain Containing 1A) Protein involved in immune cell signaling | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00174 | SHOC2 (SHOC2 Leucine Rich Repeat Scaffold Protein) A protein involved in the Ras-MAPK signaling pathway | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00175 | SLX4 (SLX4 Structure-Specific Endonuclease Subunit) A protein involved in DNA repair and chromosome crossovers | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00176 | SMAD4 (SMAD Family Member 4) A transcription factor involved in the TGF-beta signaling pathway. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00177 | SMARCA4 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 4) Protein involved in chromatin remodeling | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00178 | SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1) Protein involved in chromatin remodeling | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00179 | SMARCE1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily E, Member 1) Protein involved in chromatin remodeling. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00180 | SOS1 (SOS Ras/Rac Guanine Nucleotide Exchange Factor 1) A protein involved in Ras activation. Mutations are associated with Noonan syndrome. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00181 | SOS2 (SOS Ras/Rac Guanine Nucleotide Exchange Factor 2) A protein involved in Ras activation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00182 | SPINK1 (Serine Peptidase Inhibitor Kazal Type 1) A protein that inhibits serine proteases. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00183 | SPRED1 (Sprouty Related EVH1 Domain Containing 1) A protein that inhibits Ras/MAPK signaling pathways. Mutations are associated with Legus syndrome. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00184 | SRGAP1 (SLIT-ROBO Rho GTPase Activating Protein 1) A protein involved in the regulation of the actin cytoskeleton and cell migration. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00185 | SRP72 (Signal Recognition Particle 72) A protein involved in ribosome biogenesis and translation. Mutations may be associated with aplastic anemia. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00186 | STAT3 (Signal Transducer And Activator Of Transcription 3) A transcription factor involved in the regulation of cell growth and survival. Mutations are associated with hyper IgE syndrome (Job's syndrome) and various cancers. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00187 | STK11 (Serine/Threonine Kinase 11) A kinase that plays a role in cellular metabolism and growth. Mutations cause Peutz-Jeghers syndrome and are associated with an increased risk of various cancers. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00188 | SUFU (Suppressor Of Fused Homolog) A protein that inhibits the Hedgehog signaling pathway. Mutations are associated with medulloblastomas and other tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00189 | TERC Telomerase RNA Component) A component of telomerase that plays a role in maintaining telomere length. Mutations may be associated with dyskerosis congenita and other telomeropathies. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00190 | TERT (Telomerase Reverse Transcriptase) The catalytic subunit of telomerase. Mutations are associated with various forms of cancer and diseases associated with telomere shortening. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00191 | TINF2 (TERF1-Interacting Nuclear Factor 2) A protein involved in maintaining telomere structure. Mutations can cause dyskerosis congenita and other telomeropathies. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00192 | TJP2 (Tight Junction Protein 2) A protein involved in the formation of tight intercellular junctions. Mutations are associated with progressive familial cholestasis. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00193 | TMEM127 (Transmembrane Protein 127) A protein that plays a role in the regulation of cell growth. Mutations are associated with pheochromocytomas and paragangliomas. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00194 | TP53 (Tumor Protein p53) A transcription factor that plays a key role in tumor suppression, cell cycle regulation, and apoptosis. Mutations are associated with numerous forms of cancer. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00195 | TSC1 (Tuberous Sclerosis 1) A protein involved in the regulation of cell growth and division. Mutations cause tuberous sclerosis, characterized by benign tumors in various organs. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00196 | TSC2 (Tuberous Sclerosis 2) A protein that interacts with TSC1 to inhibit the mTOR signaling pathway. Mutations also cause tuberous sclerosis. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00197 | UBE2T (Ubiquitin Conjugating Enzyme E2 T) A protein involved in the ubiquitination process, important for protein degradation and regulation of cellular processes. Mutations are associated with Fanconi anemia syndrome. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00198 | UROD (Uroporphyrinogen Decarboxylase) An enzyme involved in heme biosynthesis. Mutations cause porphyria cutanea tardu. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00199 | VHL (Von Hippel-Lindau Tumor Suppressor) A tumor suppressor protein involved in the regulation of hypoxia. Mutations cause von Hippel-Lindau disease, characterized by multiple tumors. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00200 | WAS (Wiskott-Aldrich Syndrome) A protein involved in the regulation of the actin cytoskeleton. Mutations cause Wiskott-Aldrich syndrome, characterized by immunodeficiency and thrombocytopenia. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00201 | WNT10A (Wnt Family Member 10A)A protein involved in the Wnt signaling pathway, which is important for embryonic development and cell proliferation. Mutations can be associated with various developmental abnormalities. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00202 | WRAP53 (WD Repeat Containing Antisense to TP53)A protein that regulates telomerase stabilization and localization, and also plays a role in DNA repair. Mutations are associated with various diseases, including dyskerosis congenita. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00203 | WRN Werner Syndrome RecQ Like Helicase) A helicase involved in maintaining genomic stability. Mutations cause Werner syndrome, characterized by premature aging and an increased risk of cancer. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00204 | WT1 (Wilms Tumor 1)A transcription factor that plays a role in the development of the kidneys and gonads. Mutations are associated with Wilms tumor and other syndromes. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00205 | XPA (Xeroderma Pigmentosum, Complementation Group A) A protein involved in the repair of DNA damage caused by ultraviolet radiation. Mutations cause xeroderma pigmentosis, characterized by increased sensitivity to ultraviolet radiation and the risk of skin cancer. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00206 | XPC (Xeroderma Pigmentosum, Complementation Group C) A protein involved in the process of nucleotide excision repair of DNA. Mutations also cause xeroderma pigmentosis. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00207 | XRCC2 (X-Ray Repair Cross Complementing 2) A protein involved in homologous recombination and DNA repair. Mutations may be associated with an increased risk of various cancers. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0005.00208 | XRCC3 (X-Ray Repair Cross Complementing 3) A protein involved in homologous recombination and DNA repair. Mutations may also be associated with an increased risk of various cancers. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0012.00001 | Estrogen | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0012.00002 | Progesterone | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0012.00003 | her-2 neu | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0012.00004 | Ki-67 | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0012.00005 | PD-L1 | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0013.00001 | IHC specific | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0013.00002 | IHC non-specific | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0013.00003 | TNM classification | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0013.00004 | Molecular genetic testing | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00001 | simple amputation of the mammary gland | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00002 | radical resection of the mammary gland with lymph node dissection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00003 | lumpectomy of the mammary gland | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00004 | palliative amputation of the mammary gland with lymph node dissection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00005 | plastic surgery with TDL flap after radical resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00006 | abscess or cyst cavity drainage | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00007 | adrenalectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00008 | gastrectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00009 | liver resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00010 | ostomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00011 | resection of the duodenum | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00012 | small intestine resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00013 | extended gastrectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00014 | extended gastrectomy, with resection of the lower third of the esophagus | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00015 | hemihepatectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00016 | resection of extrahepatic ducts | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00017 | combined gastrectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00018 | combined gastrectomy, with resection of the lower third of the esophagus | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00019 | removal of retroperitoneal non-organ tumors | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00020 | distal subtotal gastrectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00021 | resection of the tail of the pancreas + splenectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00022 | proximal subtotal gastrectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00023 | removal of tumor of the anterior abdominal wall | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00024 | laparotomy, separation of adhesions (disconnection of adhesions) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00025 | economical resection of the stomach wall | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00026 | resection of the pancreas, pancreato-gastroanastomosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00027 | gastrectomy with creation of an artificial gastric-substituting reservoir (type 1) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00028 | gastrectomy with creation of an artificial gastric-substituting reservoir (type 2) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00029 | suturing of tumor perforation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00030 | combined extirpation of the gastric stump | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00031 | extirpation of the gastric stump | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00032 | resection of 2/3 of the stomach | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00033 | palliative gastrectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00034 | palliative distal subtotal gastrectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00035 | pancreatoduodenal resection (PDR) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00036 | relaparotomy, sanitation of the abdominal cavity, imposition stomas | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00037 | splenectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00038 | percutaneous transhepatic cholangiostomy (PTC) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00039 | transduodenal papillectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00040 | cholecystectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00041 | resection of esophagojejunal anastomosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00042 | transanal removal of rectal tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00043 | right hemicolectomy with ileo-transverse anastomosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00044 | left hemicolectomy with transverse-rectal anastomosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00045 | subtotal colectomy with ileo-sigmoid anastomosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00046 | sigmoidectomy with descendo-rectal anastomosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00047 | Hartmann's operation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00048 | anterior resection of the rectum with single-barrel colostomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00049 | abdominoanal resection of the rectum with pull-down | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00050 | abdominoperineal extirpation of the rectum | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00051 | total colectomy with ileostomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00052 | total colproectomy with ileostomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00053 | colostomy closure with anastomosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00054 | total colectomy with ileo-rectal anastomosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00055 | creation of reservoirs from the small intestine (j-nayч w-nayч) after total colectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00056 | creation of neorectum, neosphincter after abdominoperineal extirpation of the rectum | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00057 | anterior ultra-low resection of the rectum with the imposition of anastomosis using a circular-suturing device | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00058 | creation of colostomy, ileostomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00059 | radical nephrectomy with lymph node dissection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00060 | radical nephrectomy with lymph node dissection, thrombectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00061 | resection of the kidney | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00062 | palliative nephrectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00063 | nephroureterectomy with bladder resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00064 | diagnostic laparotomy. revision. drainage. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00065 | diagnostic laparotomy. revision. drainage. biopsy. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00066 | diagnostic laparoscopy. revision. drainage. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00067 | diagnostic laparoscopy. revision. drainage. biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00068 | relaparotomy. revision. sanitation. drainage. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00069 | TUR of the bladder | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00070 | retUR of the bladder | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00071 | resection of the bladder. epicystostomy. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00072 | revision of the bladder. biopsy. epicystostomy. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00073 | cystprostatectomy from both sides ureterocutoneostomy (UCS) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00074 | cystprostatectomy. formation of a urostomy according to Bricker | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00075 | cystprostatectomy. formation of a urinary reservoir from the colon. appendicostomy. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00076 | cystectomy from both sides ureterocutoneostomy (uks) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00077 | cystectomy. formation of a urinary reservoir from the colon. appendicostomy. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00078 | cystectomy. formation of a urostomy according to Bricker | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00079 | anterior evisceration of the pelvic organs from both sides ureterocutoneostomy (uks) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00080 | anterior evisceration of the pelvic organs. formation of a urostomy according to Bricker. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00081 | anterior evisceration of the pelvic organs. formation of a urinary reservoir from the colon. appendicostomy. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00082 | radical prostatectomy with lymph node dissection. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00083 | tour of adenoma | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00084 | adenomectomy. epicystostomy. | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00085 | orchofuniculectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00086 | Chevassu operation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00087 | retroperitoneal lymphadenectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00088 | bilateral orchiectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00089 | penectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00090 | transurethral cystolithotripsy of bladder stones | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00091 | minimally invasive surgery for external urogenital tract lesions (polypectomy, etc.) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00092 | transurethral ureterolithotripsy of ureteral stones | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00093 | ureteropyeloscopy (biopsy) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00094 | nephroscopy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00095 | sc nephrostomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00096 | sc cystostomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00097 | sc nephrolithotomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00098 | ureteroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00099 | ureteral stenting | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00100 | urethral resection. urethral plastic surgery | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00101 | hemicistectomy with ureterocystneoanastomosis. Epicystostomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00102 | Ureterocystneoanastomosis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00103 | Circumcision | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00104 | Ileal-obturator lymph node dissection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00105 | Reconstructive surgery to restore colon continuity | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00106 | Colostomy and ileostomy closure | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00107 | Cervical conization | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00108 | Laparocentesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00109 | Vulvectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00110 | Extended vulvectomy (vulvectomy and Duquesne operation) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00111 | Tubovariectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00112 | Amputation of the uterus with appendages | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00113 | Amputation of the uterus without appendages | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00114 | Extirpation of the uterus with appendages | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00115 | Extirpation of the uterus without appendages | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00116 | Extirpation of the uterus with appendages, omentectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00117 | Extended extirpation of the uterus with appendages (Wertheim operation) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00118 | Extended extirpation of the uterus with transposition of the ovaries | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00119 | Trachelectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00120 | cryodestruction of external female genitalia | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00121 | extirpation of cervical stump | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00122 | excision of skin tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00123 | excision of recurrent and metastatic skin tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00124 | excision of skin tumor with free plastic surgery | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00125 | Duquesne operation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00126 | Melnikov operation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00127 | axillary lymphadenectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00128 | free skin plastic surgery to replace postoperative defect | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00129 | excision of soft tissue tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00130 | excision of recurrent soft tissue tumor or excision of tumor metastasis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00131 | excision of tumor with vascular prosthetics | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00132 | excision of tumor with replacement of defect with vascular pedicle flap | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00133 | excochleation of tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00134 | rib resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00135 | sternal resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00136 | clavicle resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00137 | scapula resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00138 | scapulectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00139 | resection of distal humerus with autoplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00140 | resection of metacarpal bones | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00141 | resection of pelvic bones and resection of sacrum | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00142 | resection of fibula | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00143 | segmental bone resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00144 | marginal bone resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00145 | segmental bone resection with establishment Speitzer | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00146 | bone reposition with metal osteosynthesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00147 | tumor excochleation + cryo + cementoplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00148 | tumor excochleation + cryo + cementoplasty + metal osteosynthesis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00149 | tumor excochleation with cementoplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00150 | tumor excochleation with autoplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00151 | lower limb amputation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00152 | lower leg amputation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00153 | upper limb amputation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00154 | forearm amputation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00155 | hand amputation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00156 | foot amputation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00157 | upper limb disarticulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00158 | lower limb disarticulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00159 | forearm disarticulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00160 | hand disarticulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00161 | finger amputation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00162 | finger disarticulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00163 | knee joint level disarticulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00164 | ankle joint level disarticulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00165 | shoulder joint arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00166 | elbow joint arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00167 | pelvic bone arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00168 | hip joint arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00169 | knee joint arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00170 | ankle joint arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00171 | diaphyseal bone arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00172 | wrist joint arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00173 | radius bone arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00174 | endoprosthesis removal | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00175 | endoprosthesis removal with re-arthroplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00176 | endoprosthesis reconstruction | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00177 | fistula excision | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00178 | open bone tumor biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00179 | open soft tissue tumor biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00180 | excisional biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00181 | trephine biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00182 | hemipelviectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00183 | segmental bone resection with intramedullary pin placement | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00184 | segmental bone resection with autografting | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00185 | interscapular thoracic resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00186 | interscapular thoracic amputation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00187 | spinal cord tumor excision | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00188 | spinous process resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00189 | lateral process resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00190 | vertebral body resection with cage placement | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00191 | transpedicular fixator placement | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00192 | spacer removal | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00193 | scapular resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00194 | sternumectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00195 | parotid gland resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00196 | pharyngeal process resection of the parotid salivary gland via external submandibular approach | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00197 | subtotal parotid gland resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00198 | parotidectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00199 | submandibular salivary gland extirpation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00200 | hemithyroidectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00201 | subtotal thyroid resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00202 | thyroidectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00203 | laryngeal chordectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00204 | anterolateral laryngeal resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00205 | supraglottic horizontal laryngeal resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00206 | laryngectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00207 | maxillary resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00208 | combined maxillary resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00209 | diagnostic maxillary antrotomy with tumor biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00210 | maxillary antrotomy with tumor removal | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00211 | diagnostic rhinotomy with tumor biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00212 | rhinotomy with tumor removal | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00213 | diagnostic ethmoidectomy with tumor biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00214 | ethmoidectomy with tumor removal | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00215 | diagnostic pharyngotomy with tumor biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00216 | pharyngotomy with tumor removal | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00217 | laryngectomy with pharyngeal resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00218 | laryngopharyngectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00219 | laryngopharyngectomy with esophageal resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00220 | half tongue resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00221 | combined tongue resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00222 | resection of the floor of the mouth | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00223 | resection of the cheek of the oral cavity | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00224 | marginal resection of the lower jaw | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00225 | segmental resection of the lower jaw | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00226 | subtotal resection of the lower jaw | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00227 | hemimandibulectomy (half resection of the lower jaw) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00228 | reconstructive and restorative surgery for tumors of the oral cavity | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00229 | reconstructive and restorative surgery for tumors of the upper jaw | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00230 | plastic surgery for tumors of the oral cavity | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00231 | plastic surgery for tumors of the upper jaw | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00232 | excision of a skin tumor with plastic surgery | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00233 | radical removal of a tumor of the soft tissues of the head and neck | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00234 | tracheostomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00235 | ligation of the external carotid artery | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00236 | selective cervical lymph node dissection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00237 | radical cervical lymph node dissection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00238 | excision of a recurrent soft tissue tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00239 | open biopsy of a lymph node and tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00240 | excision of a metastatic tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00241 | laryngotomy with tumor biopsy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00242 | laryngoplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00243 | ligation and sclerotherapy of lymphohemangioma | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00244 | resection of the upper or lower lip with plastic surgery | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00245 | puncture biopsy of orbital tumors in children | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00246 | biopsy from orbital soft tissue tumors | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00247 | biopsy from conjunctiva and skin tumors | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00248 | surgery on the orbit | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00249 | enucleation of the eyeball | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00250 | surgery on the conjunctiva and sclera | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00251 | surgery on the skin of the eyelids | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00252 | orbital exenteration | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00253 | extended orbital exenteration | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00254 | sclerotomy, with removal of an intraocular tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00255 | lung tumor biopsy by atypical resection of the lung with a tumor | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00256 | diagnostic thoracoscopy with tumor biopsy mediastinum and pleura; | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00257 | extended (or + combined) lobectomy or bilobectomy; | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00258 | extended (or + combined) segmentectomy or atypical lung resection; | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00259 | removal (or + combined) of a tumor (metastasis, tuberculoma, chondroma, hamartochondroma, cyst, etc.) of the lung | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00260 | extended pulmonectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00261 | extended combined pulmonectomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00262 | pleurectomy with lung decortication | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00263 | rib resection with thoracomyoplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00264 | sternal resection with thoracomyoplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00265 | circular trachea resection | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00266 | removal of mediastinal tumors through thoracotomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00267 | removal of mediastinal tumors through sternotomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00268 | resection of ribs and sternum with thoracomyoplasty | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00269 | Lewis operation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00270 | Harlock-Osawa operation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00271 | abdominocervical extirpation of the esophagus with esophagogastroplasty, imposition of EGA on the neck | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00272 | McCain operation (3x accessible extirpation of the esophagus). | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00273 | Harlock operation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00274 | exploratory thoracotomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00275 | rethoracotomy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0022.00276 | thoracocentesis, drainage of the pleural cavity | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00001 | Hyperthermia | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00002 | Hyperglycemia | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00003 | Magnetotherapy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00004 | Photodynamic therapy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00005 | Radiofrequency ablation (RFA) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00006 | Local chemotherapy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00007 | Laser exposure (TTT) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00008 | Electrocoagulation | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00009 | Electrochemical lysis | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00010 | Microwave ablation (MWA) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00011 | Intravenous laser blood irradiation (IVLIB) | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00012 | Introduction of dendritic cells | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00013 | BMC Mirena | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00014 | CAR-T therapy | |||
https://terminology.dhp.uz/fhir/core/CodeSystem/cancer-types-cs | cancr0043.00015 | Blood replacement therapy |